Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP-5000 in Osteoarthritis Pain of the Knee
NCT04683627Phase 3Completed
- Sponsor
- Noven Pharmaceuticals
- Start
- Dec 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in knee osteoarthritis (OA) (2 arms), sponsored by Noven Pharmaceuticals. Primary endpoint: Change From Baseline in WOMAC Pain Score at 12 weeks. Started Dec 2020; status: completed.
02
Drugs
diclofenac
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04683627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04683627.